Clinical Trials Directory

Trials / Completed

CompletedNCT01809964

Clinical Trial to Evaluate ANT-1401 in Crow's Feet

Clinical Trial to Evaluate ANT-1401 in Subjects With Lateral Canthal Lines

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
109 (actual)
Sponsor
Anterios Inc. · Industry
Sex
All
Age
30 Years – 60 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to confirm the effect of ANT-1401 in the treatment of Lateral Canthal Lines.

Conditions

Interventions

TypeNameDescription
BIOLOGICALANT-1401
BIOLOGICALVehicle

Timeline

Start date
2013-03-01
Primary completion
2013-06-01
Completion
2013-10-01
First posted
2013-03-13
Last updated
2014-01-10

Locations

7 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01809964. Inclusion in this directory is not an endorsement.

Clinical Trial to Evaluate ANT-1401 in Crow's Feet (NCT01809964) · Clinical Trials Directory